Favipiravir Study for Coronavirus
Active — Recruiting
Have you tested positive for coronavirus (COVID-19) in the last two days? Are you interested in being in a Stanford study of an investigational treatment for COVID-19?
Active — Not Recruiting
We have recruited participants who have tested for positive for COVID-19 with mild symptoms who can be treated as outpatients. In addition to one dose of Peginterferon Lambda-1a or placebo, patients will receive serial testing to detect length of viral shedding in respiratory secretions, monitoring of clinical signs and symptoms, and will receive compensation for each visit. Participants must be 18-64 years of age and in generally good health.